Patents by Inventor Jasper Rupert Clube

Jasper Rupert Clube has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING ANAEMIA
    Publication number: 20160159896
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: February 11, 2016
    Publication date: June 9, 2016
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • METHODS OF TREATING ANAEMIA
    Publication number: 20160158357
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: February 11, 2016
    Publication date: June 9, 2016
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • METHODS OF TREATING ANAEMIA
    Publication number: 20160115545
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 28, 2016
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Methods of treating anaemia
    Patent number: 9303089
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: April 5, 2016
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • HUMAN TARGETS V
    Publication number: 20160017051
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: July 15, 2014
    Publication date: January 21, 2016
    Inventor: Jasper Rupert Clube
  • METHODS OF TREATING ANAEMIA
    Publication number: 20160017056
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: September 29, 2015
    Publication date: January 21, 2016
    Inventor: Jasper Rupert Clube
  • Methods for treating anaemia
    Patent number: 9187562
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: November 17, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision Medicine by targeting human NAV1.8 variants for treatment of pain
    Patent number: 9150660
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: October 6, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting human NAV1.9 variants for treatment of pain
    Patent number: 9139648
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: September 22, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting PD-L1 variants for treatment of cancer
    Patent number: 9109034
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: August 18, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9068012
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: June 30, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting PD-1 variants for treatment of cancer
    Patent number: 9067998
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: June 30, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision Medicine by targeting VEGF-A variants for treatment of retinopathy
    Patent number: 9062105
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: June 23, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • HUMAN TARGETS
    Publication number: 20150166677
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 18, 2015
    Inventor: JASPER RUPERT CLUBE
  • Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
    Publication number: 20150166672
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: September 18, 2014
    Publication date: June 18, 2015
    Inventor: Jasper Rupert Clube
  • HUMAN TARGETS
    Publication number: 20150166673
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: September 29, 2014
    Publication date: June 18, 2015
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9051378
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: June 9, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting PD-L1 variants for treatment of cancer
    Patent number: 9045545
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: June 2, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9045548
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: June 2, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9040052
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: May 26, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube